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Abstract
Background: National smoking cessation strategies in Nigeria are hindered by lack of up-to-date epidemiologic
data. We aimed to estimate prevalence of tobacco smoking in Nigeria to guide relevant interventions.
Methods: We conducted systematic search of publicly available evidence from 1990 through 2018. A random-
effects meta-analysis and meta-regression epidemiologic model were employed to determine prevalence and
number of smokers in Nigeria in 1995 and 2015.
Results: Across 64 studies (n = 54,755), the pooled crude prevalence of current smokers in Nigeria was 10.4% (9.0–
11.7) and 17.7% (15.2–20.2) for ever smokers. This was higher among men compared to women in both groups.
There was considerable variation across geopolitical zones, ranging from 5.4% (North-west) to 32.1% (North-east) for
current smokers, and 10.5% (South-east) to 43.6% (North-east) for ever smokers. Urban and rural dwellers had
relatively similar rates of current smokers (10.7 and 9.1%), and ever smokers (18.1 and 17.0%). Estimated median age
at initiation of smoking was 16.8 years (IQR: 13.5–18.0). From 1995 to 2015, we estimated an increase in number of
current smokers from 8 to 11 million (or a decline from 13 to 10.6% of the population). The pooled mean cigarettes
consumption per person per day was 10.1 (6.1–14.2), accounting for 110 million cigarettes per day and over 40
billion cigarettes consumed in Nigeria in 2015.
Conclusions: While the prevalence of smokers may be declining in Nigeria, one out of ten Nigerians still smokes
daily. There is need for comprehensive measures and strict anti-tobacco laws targeting tobacco production and
marketing.
Keywords: Smoking, Tobacco, Prevalence, Non-communicable diseases, Risk, Nigeria
Introduction
Smoking is a leading cause of preventable deaths and
morbidity, linked to high burden of lung cancer, chronic
obstructive pulmonary disease (COPD), ischemic heart
diseases and stroke [1–3]. It accounts for more than 7
million deaths annually with about 10% of these
resulting from second-hand smoke [2]. There are
around 1.1 billion smokers worldwide and about 80%
of these live in low- and middle-income countries
(LMICs), where more than two-thirds of smoking-
related deaths occur [2].
Though global current smoking rates among adults
decreased from 23.5 to 20.7% between 2007 and 2015
[4], this reduction was largely due to the declining smok-
ing rates in Northern and Western Europe, North Amer-
ica and the Western Pacific regions [3, 4], where
considerable measures have been implemented to tackle
tobacco smoking. Conversely, smoking rate appears to
be increasing in the Middle East and Africa [4]. For ex-
ample, in sub-Saharan Africa, the consumption of to-
bacco increased by 57% between 1990 and 2009 [5]. A
recent analysis of the Demographic Health Survey data
of 30 sub-Saharan African countries revealed higher
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smoking rates, with prevalence as high as 37.7% among
men in Sierra Leone [6].
Nigeria is the most populous country in Africa and
has one of the leading tobacco markets in Africa, with
over 18 billion cigarettes sold annually costing Niger-
ians over US$ 931 million [7, 8]. Following the 2003
World Health Organization (WHO) Framework Con-
vention on Tobacco Control (FCTC) [2], Nigeria rati-
fied the convention agreement in 2005, and in 2015
signed into law the National Tobacco Control (NTC)
Act that regulates all aspects of tobacco control includ-
ing advertising, packaging, and smoke-free areas [2].
Despite these initiatives, some reports suggest the
prevalence of smoking in the country is rising at about
4% per year [8].
The WHO estimated about 13 million smokers in
Nigeria in 2012 [7], with over 16,000 deaths attribut-
able to smoking [9]. Increased commerce by inter-
national tobacco companies and the relative role they
play in economic growth may have contributed to a
rise in smoking rates [8, 10]. Although, some national
estimates of smoking prevalence have been reported
[11, 12], the exact number of smokers remains de-
bated, which possibly hinders health policy. Concerns
over current estimates include varying case defini-
tions, representativeness of study samples or data, and
poor study designs. We therefore conducted a com-
prehensive systematic search of the literature and
synthesized data based on standard case definitions to
estimate national and sub-national prevalence of
smoking in Nigeria.
Methods
This is a review of publicly available studies and con-
ducted as part of series on the epidemiology of non-
communicable diseases (NCDs) in Nigeria. Methods
have been described in detail in previous studies [13–
16]. No ethical approval was required. Study was con-
ducted in line with the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) guide-
lines [17].
Search strategy
We searched MEDLINE, EMBASE, Global Health and
Africa Journals Online (AJOL) on 31 January 2019.
We initially searched for epidemiological studies on
smoking in Nigeria and sourced for unpublished re-
ports (or studies) from Google searches and Google
Scholar. We included studies that were (i) population-
based, (ii) reporting on the prevalence of smoking
(current or ever) in a Nigerian setting, and (iii) pub-
lished on or after 01 January 1990. Search terms are
presented in the Additional file 1.
Case definitions
We selected studies that defined smoking as “smoking of
tobacco products, be it cigarettes, bidi, cigar, hookah,
pipe, or other related manufactured products and hand
rolled stuffs”. We defined current smoker as someone
who smokes every day, or some days in the last 30 days
preceding an interview. An ex-smoker (or former
smoker) is someone who was an every-day smoker or
has smoked at least 100 cigarettes in his or her lifetime
but has currently quit smoking [2, 18, 19]. An ever
smoker is defined as anyone who has quit smoking
(smoked at least 100 cigarettes in their lifetime) or cur-
rently smokes. This describes life-time smoking status
and satisfies the definition of either a current or former
smoker [19, 20].
Data extraction
DA and AA independently reviewed and assessed studies
using a pre-defined guideline to ensure consistency in
studies’ selection (disagreements were resolved by con-
sensus). From each study, we extracted number of
smokers, sample size, mean (or median) age, and esti-
mated prevalence of smoking (and confidence intervals
(CI). These were matched to the study period, site, geo-
political zone and setting, respectively. Quality of studies
was assessed during data extraction, adapting a previ-
ously used guideline [21–24]. This was based on repre-
sentativeness of the sample, appropriate design and
analysis, and standard case definitions, with each study
graded as high, moderate, or low (Additional file 1).
Data analysis
We employed a random-effects meta-analysis, using
the DerSimonian and Laird Method [25], to combine
individual study estimates and generate national and
sub-national pooled estimates of the prevalence of to-
bacco smoking in Nigeria. Assuming a binomial (or
Poisson) distribution, we estimated standard errors
from crude prevalence and sample. Heterogeneity was
identified from subgroup analyses, and assessed using
I-squared (I2) statistics. To show trends and changes
in smoking prevalence in the country, a meta-
regression model accounting for the study period, and
age was developed. Age-adjusted prevalence estimates
were generated from the model for years 1995 and
2015. These were employed to estimate the absolute
number of current and ever smokers in Nigeria based
on the United Nations population (five-year age
groups) for Nigeria for the two years [26]. This model
has been described in detail in previous studies [13–
16]. All statistical analyses were conducted on Stata
(Stata Corp V.14, Texas, USA).
Adeloye et al. BMC Public Health         (2019) 19:1719 Page 2 of 14
Results
Search results
A total of 1474 records were retrieved from the data-
bases – 546 studies in MEDLINE, 654 in EMBASE, 229
in Global Health, and 45 in AJOL. Twenty-two studies
were identified from additional searches. We screened
967 titles were for relevance (i.e. epidemiologic studies
on smoking in Nigeria) after removing duplicates, with
794 articles excluded. Abstracts and full-texts of the
remaining 173 articles were accessed and screened. We
retained 64 studies for synthesis (Fig. 1).
Study characteristics
The 64 studies covered the six geopolitical zones of
Nigeria (Table 1). The South-west returned 40.6% (26
studies) of all selected articles, followed by South-south
(19%, 12 studies), and South-east and North-central
(13%, 8 studies). The North-west was covered in four
studies (6.3%), while the North-east had the lowest
coverage with two studies (3.1%). Most studies (77.1%,
43 studies) were conducted in urban settings, while rural
settings had 10 studies (15.6%), and 11 studies (17.2%)
were from mixed urban and rural settings. Using our
quality criteria, 25 studies (39%) were rated as high qual-
ity, and 39 (61%) rated as moderate. All studies were
conducted under one year, with study year ranging from
1990 to 2017. The total population covered from all se-
lected studies was 54,755, with the mean (or median)
age of samples ranging from 15 to 55.5 years (Table 1
and Additional file 1). Heterogeneity was high across
studies, with I-squared (I2) estimated at 98.2%
(P < 0.001). This was generally high (I2> 95%) across
subgroups (ie. sex, geopolitical zones, geographical set-
tings) (Table 2).
Prevalence of tobacco smoking in Nigeria
Current smokers
The prevalence of current smokers ranged from 1.2% re-
corded in Yaba Lagos, South-west Nigeria in 2015 [44],
to 55.5% in Amassoma Delta State, South-south Nigeria,
also in 2015 [69]. The pooled crude prevalence of
current smokers in Nigeria was 10.4% (95% CI: 9.0–
11.7), with this significantly lower among women (3.6%,
2.8–4.4), compared to men (13.4%, 10.0–16.8) (Table 2).
Following a sensitivity analysis, the prevalence of current
smokers in the general population at 8.8% (7.5–10.2)
Fig. 1 Flow chart of selection of studies on tobacco smoking in Nigeria
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was comparable to the overall pooled estimate (10.4%),
while a higher estimate was reported among specific
populations (eg. commercial drivers, soldiers, and
healthcare students) at 17.3% (11.5–23.1) (Fig. 2). Across
the geopolitical zones, the prevalence rate of current
smokers was significantly higher in the North-east
(32.1%, 30.0–34.1), compared to the other five geopolit-
ical zones. The South-south region had a prevalence of
13.0% (8.7–17.3), North-central 10.3% (6.0–14.4), South-
west 8.9% (6.9–11.0), South-east 8.6% (4.1–13.0) and
North-west 5.4% (3.7–7.2) (Table 2). There was relatively
no difference in the prevalence of current smokers
across geographical settings, with the urban and
rural settings having a prevalence of 10.7% (8.8–
12.6) and 9.1% (5.1–13.0), respectively (Table 2 and
Additional file 1).
Ever smokers
The lowest prevalence of ever smokers was recorded in
Ibadan Oyo State, South-west Nigeria in 2009 at 2.1%
[77], while the highest was reported in Amassoma Delta
State, South-south Nigeria in 2015 at 64.6% [69]. The
pooled crude prevalence of ever smokers (i.e. life-time
prevalence of smoking) was 17.7% (95% CI: 15.2–20.2)
Fig. 2 Crude prevalence rate of current smokers in Nigeria
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(Table 2). As observed among current smokers, the
prevalence was significantly higher among men at 22.8%
(17.5–28.2), compared to women at 6.3% (4.8–7.7)
(Table 2). When population characteristics were consid-
ered in the sensitivity analysis, the prevalence of ever
smokers in the general population was 15.3% (12.9–
17.6), which was comparable to the overall estimate
(17.7%), in contrast to a relatively higher estimate among
specific population groups at 30.7% (17.7–43.7) (Fig. 3).
The pooled prevalence of ever smokers was highest in
the North-east at 43.6% (31.5–55.7), with lowest re-
corded in the South-east at 10.5% (3.7–17.4) and the
North-west at 12.4% (7.9–16.9). The South-south and
South-west have a relatively similar pooled prevalence
rates of ever smokers at 16.9% (11.4–22.3) and 17.1%
(12.8–21.4), respectively. The pooled prevalence was
minimally higher in urban settings at 18.1% (14.6–
21.6) compared to rural settings at 16.8% (10.8–22.8)
(Table 2).
Age at initiation of smoking
Most studies reported the mean or median age at initi-
ation of smoking during adolescence, with this ranging
from 12 years in Ibadan Oyo State, South-west Nigeria
[55], to 21.9 years in Lagos Mainland, South-west
Nigeria [72]. From all studies, the estimated median age
Fig. 3 Crude prevalence rate of ever smokers in Nigeria
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at initiation of smoking was 16.75 years (interquartile
range: 13.5–18.0).
Estimated number of current and ever smokers in Nigeria
Based on the model, the age-adjusted prevalence of
current smokers decreased with advancing age, while the
prevalence increased with advancing age for ever
smokers (Table 3). Using the United Nations demo-
graphic projections for Nigeria, we estimated about 8
million current smokers in Nigeria in 1995 among per-
son aged 15 years or more, with this increasing to about
11 million current smokers by 2015. The age-adjusted
prevalence of current smokers actually decreased from
13.0 to 10.6% over this period (Table 3). On the con-
trary, both the prevalence and number of ever smokers
increased over the same period, from about 10.9 million
(17.6%) in 1995 to 19.8 million (19.2%) in 2015 (Table
3).
Cigarettes consumed per day
Among current smokers, the mean cigarettes consumed
per person per day ranged from 2 (1.0–3.4) recorded in
a semi-urban setting in Abraka Delta State, South-south
Nigeria [31], to 23.7 (21.3–26.1) in a rural area in Oyo
State, Nigeria [81]. The pooled mean cigarettes con-
sumption per person per day from all studies was 10.1
(6.1–14.2) (Table 3, Fig. 4). When considered in terms
of the absolute number of current smokers in Nigeria in
2015 (11 million), this accounts for about 110 million
cigarettes per day and over 40 billion cigarettes in
Nigeria in 2015.
Discussion
This study integrated smoking information from 64
moderate to high-quality studies to estimate the current
prevalence of smoking in Nigeria. Although the preva-
lence of ever smokers increased between 1995 and 2015,
we observed a decreasing prevalence of current smokers
over the same period. This trend is in contrast to esti-
mates reported, albeit based on limited data, in some
countries insub-Saharan Africa, who have experienced
rising smoking rates due to changing socio-economic
status, rural-urban migration and increased cigarette af-
fordability [91]. The decreasing smoking rates in Nigeria
possibly reflect increased health risk awareness and bet-
ter overall measures to help smokers quit in the country.
For example, in a national survey, Kale and colleagues
[92] reported that in the 12 months preceding their
study, almost half of current smokers attempted to quit
smoking, with over two-thirds of these receiving advice
from care providers and counselors.
Despite the declining rates, we estimated about 11 mil-
lion current smokers (10.6%) and 20 million ever
smokers (19.2%) in 2015, which are still unacceptably
high from an absolute perspective. In a nation-wide sur-
vey in 2012 [11], the prevalence of current smokers was
4% among adults Nigerians. This is much lower than es-
timated in this study, presumably due to challenges with
sampling and case ascertainment. In a recent scoping ex-
ercise, Adeoye et al. [93] estimated a prevalence of
current smokers at 19.7%. However, this estimate was
not age-standardized, and a lower prevalence of ever
smokers reported raises concerns on the quality of data.
However, in 2015, the WHO reported a current smoking
prevalence of about 9% among persons aged 15 years or
more (17% among men and 1% among women) in
Nigeria [7]. The overall prevalence and sex distribution
are almost as reported in the current study. The higher
smoking prevalence among men in Nigeria is well-
documented [10, 93]. This perhaps represents a sus-
tained pattern of smoking epidemic, and presents a valu-
able opportunity for developing effective policies and
interventions learning from actions in developing coun-
tries [94, 95].
The median age at initiation of smoking in this study
(16.8 years) is relatively low, reflective of a growing bur-
den among adolescents and youths. Kale and colleagues
[92] in their nation-wide survey noted that about two-
thirds of the population started smoking before attaining
20 years. Adeoye et al. [93] reported lower age at initi-
ation of 14.7 years in the country. Many have advocated
for stiffer anti-tobacco laws in the country, particularly
Table 3 Absolute number of current and ever smokers in
Nigeria, aged 15 years or more, 1995 and 2015
Age
(years)
Current smokers Ever smokers
1995 2015 1995 2015
% n (000) % n (000) % n (000) % n (000)
15–24 13.8 1633.5 11.4 2127.4 16.1 1913.7 17.7 3291.8
20–24 13.5 1316.7 11.2 1791.6 16.5 1610.6 18.1 2897.3
25–29 13.3 1039.7 11.0 1543.5 17.0 1327.3 18.6 2608.4
30–34 13.1 861.6 10.8 1302.2 17.4 1147.4 19.0 2299.3
35–39 12.9 711.4 10.5 1051.7 17.9 988.1 19.4 1940.0
40–44 12.6 582.5 10.3 800.8 18.3 843.4 19.9 1543.4
45–49 12.4 483.1 10.1 605.9 18.7 729.1 20.3 1220.0
50–54 12.2 405.7 9.9 492.4 19.2 638.2 20.7 1035.7
55–59 12.0 321.7 9.6 399.5 19.6 527.3 21.2 877.9
60–64 11.7 245.3 9.4 312.9 20.0 418.8 21.6 718.7
65–69 11.5 177.7 9.2 234.6 20.5 316.1 22.0 563.0
70–74 11.3 116.4 9.0 163.2 20.9 215.6 22.5 409.5
75–79 11.1 64.3 8.7 94.1 21.3 124.1 22.9 246.9
80+ 10.7 37.8 8.4 60.5 22.0 77.8 23.6 170.4
All 13.0 7997.4 10.6 10,980.3 17.6 10,877.3 19.2 19,822.3
Note: Estimates based on the epidemiologic modelling from all datapoints
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to address a growing use of tobacco products among
youths [11].
The prevalence of smokers was notably higher in
North-east Nigeria which may be expected given an on-
going armed conflict lasting more than a decade. Al-
though the evidence of the association between smoking
and conflict is limited and inconclusive [96], varying so-
cial situations among vulnerable populations are known
to precipitate substance use [97]. With several persons
displaced, children and adolescents out of school, and
youths without jobs, substance use, including tobacco
products, is likely to increase in these settings. Although
Kale and colleagues [92] reported South-easterners as
the highest consumers of tobacco products in the coun-
try, the deviance from our estimates suggests a need for
more research to understand regional variations.
Although the NTC Act was signed into law in 2015
and the country has committed to the WHO FCTC
since 2005 [18], Nigeria is not yet on track to achieve to-
bacco control targets [98]. For example, our estimates
show that rural dwellers smoke almost at the same rate
as urban dwellers, indicating that smoking, believed to
be associated with urbanization, has gradually penetrated
remote areas. Further, we estimated that current
smokers consume an average of 10 cigarettes per person
per day accounting for about 110 million cigarettes per
day and over 40 billion cigarettes in 2015 alone. Vellios
et al. [99] noted that the demand for cigarettes increased
by 44% across many African countries between 1990 and
2012, with this leading to over 100% increase in ciga-
rettes production over the same period in these coun-
tries. A thriving tobacco market raises serious public
health concerns, particularly for a country with a rela-
tively weak health system. Tobacco companies see these
countries as emerging markets due to weak tobacco con-
trol regulations and several vulnerable populations [91,
94]. Careful incorporation of the WHO MPOWER pack-
age (targeted at reversing tobacco epidemic) [18] beyond
the national level to state and local levels may comple-
ment successful measures like smoke-free legislation,
taxes, health education and media campaigns [2, 7]. Be-
sides, Nigeria needs to develop comprehensive surveil-
lance systems to monitor the production, sales, and
consumption of cigarettes to effectively achieve control
targets [99].
The strength of this review lies in the number of stud-
ies retained (64) and population covered (54755), which
spread across all geopolitical zones in the country.
Herein, we have perhaps addressed an issue bordering
on representativeness, which appears to be a leading
concern in the understanding of the epidemiology of
smoking in Nigeria [10]. We acknowledge that pooling
prevalence rates from a range of studies conducted over
a 27-year period (1990–2017) could affect reliability of
our overall estimates; however, this was mainly done to
understand the trend in smoking rates over this period,
which our model and age-adjusted estimates clearly re-
flect (Table 3). Nonetheless, our estimates should be
considered with the high heterogeneity reported. This
perhaps could be due to diverse population characteris-
tics, particularly those contributed by specific population
groups. Our sensitivity analysis may have addressed this
(ie. comparing general to specific populations), as ex-
cluding some of specific populations with higher preva-
lence of smoking could imply missing some necessary
information on the use of tobacco and related products
in the country. Varying study designs are also important
sources of heterogeneity. Due to data limitations, we
could not investigate other sources of heterogeneity, in-
cluding socio-economic status, wealth index, employ-
ment status and religion. Finally, there were only two
studies from the North-east, this should guide interpret-
ation of the high estimates in the region.
Conclusion
While the prevalence of current smokers may be declin-
ing in Nigeria, the absolute number of active smokers
remain one of the highest in Africa. Economic growth,
improved socio-economic status, rapid migration, and
increased cigarette affordability are key factors. As rural
Fig. 4 Pooled mean cigarettes consumed per person per day in Nigeria
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dwellers are almost as affected as urban dwellers, careful
consideration is required during programming. Compre-
hensive measures and strict anti-tobacco laws targeting
tobacco production and marketing need to be enforced
across country levels.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12889-019-8010-8.
Additional file 1: Table S1. Search terms on tobacco smoking in
Nigeria. Table S2. Quality assessment of selected studies. Table S3.
Quality appraisal guide. Table S4. All extracted data employed in
analysis. Figure S1. Crude prevalence rate of current smokers in Nigeria,
by geopolitical zones. Figure S2. Crude prevalence rate of ever smokers
in Nigeria, by geopolitical zones. Figure S3. Pooled mean cigarettes
consumed per person per day in Nigeria. Figure S4. Meta-regression
modelling.
Abbreviations
AJOL: Africa Journals Online; COPD: Chronic Obstructive Pulmonary Disease;
FCTC: Framework Convention on Tobacco Control; LMICs: Low- and Middle-
Income Countries; NCDs: Non-Communicable Diseases; NTC: National
Tobacco Control; PRISMA: Preferred Reporting Items for Systematic Reviews
and Meta-Analyses; WHO: World Health Organization
Acknowledgements
The authors acknowledge the support of the Nigeria Federal Ministry of
Health and the WHO Nigeria Country Office in the conduct of this study.
Special thanks to the Centre for Global Health, and the NIHR Global Health
Respiratory Unit (RESPIRE), Usher Institute, University of Edinburgh, UK.
Authors’ contributions
DA conceived and designed the study. DA and AA conducted the literature
searches and data extraction. DA and AA wrote the first draft. DA and MOH
conducted the analysis. DA, AA, MTD, CO, AF, MG, NE, RGM, WA, MOH, and
IFA contributed to the final draft and checked for important intellectual
content. All authors approved the manuscript as submitted.
Funding
MOH is supported by a grant (K99HL141678) from the NIH/National Heart,
Lung, and Blood Institute (NHLBI). NHLBI had no role in the design of the
study, collection, analysis, and interpretation of data, and in writing the
manuscript.
Availability of data and materials
All data generated or analysed during this study are included in this
published article [and its supplementary information files].
Ethics approval and consent to participate
This is a review of publicly available studies. No ethical approval was
required.
Consent for publication
Not applicable.
Competing interests
The authors declare no conflicts of interest.
Author details
1Centre for Global Health, Usher Institute, University of Edinburgh, 30 West
Richmond street, Edinburgh EH8 9DX, UK. 2RcDavies Evidence-based
Medicine, Lagos, Nigeria. 3School of Pharmacy and Biomedical Sciences,
University of Central Lancashire, Fylde Road, Preston, UK. 4Department of
Medicine, University of Ilorin, Ilorin, Nigeria. 5Department of Community
Medicine, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria.
6Federal Ministry of Health, Abuja, Nigeria. 7WHO Nigeria Country Office,
Abuja, Nigeria. 8International Health Consultancy, LLC, Atlanta, GA, USA.
9Department of Biostatistics, Epidemiology and Informatics, Perelman School
of Medicine University of Pennsylvania, Philadelphia, PA, USA. 10Palliative and
Advanced Illness Research (PAIR) Center, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, PA, USA. 11College of Medicine,
University of Ibadan, Ibadan, Nigeria.
Received: 24 June 2019 Accepted: 27 November 2019
References
1. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced
cancer. Nat Rev Cancer. 2003;3(10):733.
2. World Health Organization. WHO Report on the Global Tobacco Epidemic,
2019. Geneva: World Health Organization; 2019. Available from: https://apps.
who.int/iris/bitstream/handle/10665/326043/9789241516204-eng.pdf.
Accessed 3 Nov 2019.
3. Drope J, Schluger N, Cahn Z, Drope J, Hamill S, Islami F, et al The Tobacco
Atlas. Atlanta: American Cancer Society and Vital Strategies. 2018.
4. Scollo M, Winstanley M. Tobacco in Australia: facts and issues. Melbourne:
Cancer Council Victoria. 2018.
5. Eriksen M, Nyman A, Whitney C. Global tobacco use and cancer: findings
and solutions from the tobacco atlas. 2014. Available from: http://
cancercontrol.info/wp-content/uploads/2014/08/43-48-Eriksen_cc2014.pdf.
28 December 2018
6. Sreeramareddy CT, Pradhan PM, Sin S. Prevalence, distribution, and social
determinants of tobacco use in 30 sub-Saharan African countries. BMC Med.
2014;12(1):243.
7. World Health Organization. WHO global report on trends in tobacco
smoking 2000–2025. Geneva: World Health Organization; 2015. Available
from: https://www.who.int/tobacco/publications/surveillance/
reportontrendstobaccosmoking/en/. Accessed 21 Jan 2019.
8. Ake A. Nigeria: Tobacco Consumption Contributes 12% Deaths From Heart
Diseases - NHF. THISDAY. 2018 17 May 2018.
9. The Tobacco Atlas. Nigeria. Available from: https://tobaccoatlas.org/country/
nigeria/. Accessed 28 Dec 2018.
10. Oyewole BK, Animasahun VJ, Chapman HJ. Tobacco use in Nigerian youth:
A systematic review. PloS One. 2018;13(5):e0196362.
11. Adeniji F, Bamgboye E, van Walbeek C. Smoking in Nigeria: Estimates from
the Global Adult Tobacco Survey (GATS) 2012. Stroke. 2016;2:3.
12. Mbulo L, Kruger J, Hsia J, Yin S, Salandy S, Orlan EN, et al. Cigarettes point of
purchase patterns in 19 low-income and middle-income countries: Global
Adult Tobacco Survey, 2008–2012. Tobacco Control:2018.
13. Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of
the prevalence of hypertension in Nigeria: a systematic review and meta-
analysis. J Hypertens. 2015;33(2):230–42.
14. Adeloye D, Ige JO, Aderemi AV, Adeleye N, Amoo EO, Auta A, et al.
Estimating the prevalence, hospitalisation and mortality from type 2
diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ
Open. 2017;7(5):e015424.
15. Adeloye D, Olawole-Isaac A, Auta A, Dewan MT, Omoyele C, Ezeigwe N,
et al. Epidemiology of harmful use of alcohol in Nigeria: a systematic review
and meta-analysis. The Am J Drug Alcohol Abuse. 2019;45(5):438–50.
16. Adeloye D, Abaa DQ, Owolabi EO, Ale BM, Mpazanje RG, Dewan MT, et al.
Prevalence of hypercholesterolemia in Nigeria: a systematic review and
meta-analysis. Public Health. 2019;178:167–78.
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. PLoS
Medicine. 2009;6(7):e1000097.
18. World Health Organization. MPOWER: a policy package to reverse the
tobacco epidemic. Geneva: World Health Organization; 2008.
19. Centre for Disease Control and Prevention (CDC). Adult Tobacco Use Information:
National Health Interview Survey: CDC; 2017. Available from: https://www.cdc.
gov/nchs/nhis/tobacco/tobacco_glossary.htm. [02 October 2019]
20. Parekh TM, Wu C, McClure LA, Howard VJ, Cushman M, Malek AM, et al.
Determinants of cigarette smoking status in a national cohort of black and
white adult ever smokers in the USA: a cross-sectional analysis of the
REGARDS study. BMJ Open. 2019;9(5):e027175.
21. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The
epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic
review and meta-analysis. The Lancet Global Health. 2014;2(3):e174–e81.
Adeloye et al. BMC Public Health         (2019) 19:1719 Page 12 of 14
22. Pai M, McCulloch M, Gorman JD, Pai N, Enanoria W, Kennedy G, et al.
Systematic reviews and meta-analyses: an illustrated, step-by-step guide.
Natl Med J India. 2004;17:86–95.
23. Guyatt GH, Rennie D. Users' guides to the medical literature: a manual for
evidence-based clinical practice Chicago: AMA Press; 2002.
24. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the
quality of controlled clinical trials. BMJ. 2001;323:42–6.
25. DerSimonian R, Laird N. Meta-Analysis in Clinical Trials. Control Clin Trials.
1986;7:177–88.
26. United Nations. 2017 Revision of World Population Prospects. New York, US:
United Nations; 2017. Available from: https://esa.un.org/unpd/wpp/.
Accessed 28 Dec 2018.
27. Obaseki D, Erhabor G, Burney P, Buist S, Awopeju O, Gnatiuc L. The
prevalence of COPD in an African city: Results of the BOLD study, Ile-Ife,
Nigeria. Eur Respiratory Soc. 2013.
28. Desalu OO. Prevalence of chronic bronchitis and tobacco smoking in some
rural communities in Ekiti state, Nigeria. The Niger Postgrad Med J. 2011;
18(2):91–7.
29. Harris-Eze AO. Smoking habits and chronic bronchitis in Nigerian soldiers.
East Afr Med J. 1993;70(12):763–7.
30. Ozoh O, Balogun B, Oguntunde O, Nwizu C, Roberts A, Inem V, et al. The
prevalence and determinants of COPD in an urban community in Lagos,
Nigeria. Eur Respiratory Soc. 2013.
31. Arute J, Oyita G, Eniojukan J. Substance Abuse among Adolescents: 2.
Prevalence and Patterns of Cigarette smoking among senior secondary
school students in Abraka, Delta State, Nigeria. IOSR J Pharm. 2015;5(1):40–7.
32. Abiola A, Balogun O, Odukoya O, Olatona F, Odugbemi T, Moronkola R,
et al. Age of initiation, Determinants and Prevalence of Cigarette Smoking
among Teenagers in Mushin Local Government Area of Lagos State,
Nigeria. APJCP. 2016;17(3):1209–14.
33. Adebiyi AO, Faseru B, Sangowawa AO, Owoaje ET. Tobacco use amongst
out of school adolescents in a Local Government Area in Nigeria. Subst
Abuse Treat Prev Policy. 2010;5:24.
34. Adepoju EG, Olowookere SA, Adeleke NA, Afolabi OT, Olajide FO, Aluko OO.
A population based study on the prevalence of cigarette smoking and
smokers' characteristics at osogbo,Nigeria. Tobacco Use Insights. 2013;6:1–5.
35. Agaba EI, Akanbi MO, Agaba PA, Ocheke AN, Gimba ZM, Daniyam S, et al. A
survey of non-communicable diseases and their risk factors among
university employees: a single institutional study. Cardiovascular J Afr. 2017;
28(6):377–84.
36. Agaku IT, Filippidis FT. Prevalence, determinants and impact of unawareness
about the health consequences of tobacco use among 17,929 school
personnel in 29 African countries. BMJ open. 2014;4(8):e005837.
37. Aina BA, Oyerinde OO, Joda AE, Dada OO. Cigarette smoking among
healthcare professional students of University of Lagos and Lagos University
Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria. Niger Q J Hospital Med.
2009;19(1):42–6.
38. Azodo CC, Omili M. Tobacco use, Alcohol Consumption and Self-rated Oral
Health among Nigerian Prison Officials. Int J Prev Med. 2014;5(11):1364–71.
39. Awopeju O, Erhabor G, Awosusi B, Awopeju O, Adewole O, Irabor I.
Smoking prevalence and attitudes regarding its control among health
professional students in South-Western Nigeria. Annals Med Health Sci Res.
2013;3(3):355–60.
40. Anyanwu OU, Ibekwe RC, Ojinnaka NC. Pattern of substance abuse among
adolescent secondary school students in Abakaliki. Cogent Med. 2016;3(1):
1272160.
41. Akinbodewa AA, Adejumo AO, Koledoye OV, Kolawole JO, Akinfaderin D,
Lamidi AO, et al. Community screening for pre-hypertension, traditional risk
factors and markers of chronic kidney disease in Ondo State, South-Western
Nigeria. The Niger Postgrad Med J. 2017;24(1):25–30.
42. Babatunde LS, Babatunde OT, Oladeji SM, Ashipa T. Prevalence and
determinants of susceptibility to cigarette smoking among non-smoking
senior secondary school students in Ilorin, North Central Nigeria. Int J
Adolesc Med Health. 2017.
43. Babatunde OA, Elegbede OE, Ayodele LM, Atoyebi OA, Ibirongbe DO,
Adeagbo AO. Cigarette Smoking Practices and Its Determinants
Among University Students in Southwest, Nigeria. J Asian Sci Res.
2012;2(2):62–9.
44. Dania MG, Ozoh OB, Bandele EO. Smoking habits, awareness of risks, and
attitude towards tobacco control policies among medical students in Lagos
Nigeria. Ann Afr Med. 2015;14(1):1–7.
45. Desalu O, Olokoba A, Danburam A, Salawu F, Issa B. Epidemiology of
tobacco smoking among adults population in north-east Nigeria. The
Internet J Epidemiol. 2008;6(1).
46. Desalu OO, Salami AK, Fawibe AE. Prevalence of cough among adults in an
urban community in Nigeria. West Afr J Med. 2011;30(5):337–41.
47. Ebirim CIC, Amadi AN, Abanobi OC, Iloh GUP. The prevalence of cigarette
smoking and knowledge of its health implications among adolescents in
Owerri, South-Eastern Nigeria. Health. 2014;6(12):1532–8.
48. Ekanem US, Opara DC, Akwaowo CD. High blood pressure in a semi-urban
community in south-south Nigeria: a community-based study. African
health sciences. 2013;13(1):56–61.
49. Emerole CO, Aguwa EN, Onwasigwe CN, Nwakoby BA. Cardiac risk indices
of staff of Federal University Of Technology Owerri, Imo State, Nigeria.
Tanzania Health Res Bull. 2007;9(2):132–5.
50. Fatoye FO, Morakinyo O. Substance use amongst secondary school students
in rural and urban communities in south western Nigeria. East Afr Med J.
2002;79(6):299–305.
51. Fawibe A, Shittu A. Prevalence and characteristics of cigarette smokers
among undergraduates of the University of Ilorin, Nigeria. Niger J Clin Pract.
2011;14(2):201–5.
52. Hussain NA, Akande TM, Adebayo O. Prevalence of cigarette smoking and
the knowledge of its health implications among Nigerian soldiers. East Afr J
Public Health. 2009;6(2):168–70.
53. Ibekwe R. Modifiable Risk factors of Hypertension and Socio-demographic
Profile in Oghara, Delta State; Prevalence and Correlates. Annals Med Health
Sci Res. 2015;5(1):71–7.
54. Makanjuola AB, Daramola TO, Obembe AO. Psychoactive substance use
among medical students in a Nigerian university. World Psychiatry.
2007;6(2):112–4.
55. Morakinyo J, Odejide AO. A community based study of patterns of
psychoactive substance use among street children in a local government
area of Nigeria. Drug Alcohol Depend. 2003;71(2):109–16.
56. Obot IS. The use of tobacco products among Nigerian adults: a general
population survey. Drug Alcohol Depend. 1990;26(2):203–8.
57. Odey FA, Okokon IB, Ogbeche JO, Jombo G, Ekanem E. Prevalence of
cigarette smoking among adolescents in Calabar city, south-eastern Nigeria.
J Med Med Sci. 2012;3(4):237–42.
58. Odeyemi KA, Osibogun A, Akinsete AO, Sadiq L. The Prevalence and
Predictors of Cigarette Smoking among Secondary School Students in
Nigeria. The Niger Postgrad Med J. 2009;16(1):40–5.
59. Odugbemi TO, Onajole AT, Osibogun AO. Prevalence of cardiovascular risk
factors amongst traders in an urban market in Lagos, Nigeria. The Niger
Postgrad Med J. 2012;19(1):1–6.
60. Lawoyin TO, Asuzu MC, Kaufman J, Rotimi C, Owoaje E, Johnson L, et al.
Prevalence of cardiovascular risk factors in an African, urban inner city
community. West Afr J Med. 2002;21(3):208–11.
61. Ige OK, Owoaje ET, Adebiyi OA. Non communicable disease and risky
behaviour in an urban university community Nigeria. Afr Health Sci. 2013;
13(1):62–7.
62. Ugwuja E, Ogbonna N, Nwibo A, Onimawo I. Overweight and Obesity, Lipid
Profile and Atherogenic Indices among Civil Servants in Abakaliki, South
Eastern Nigeria. Annals Med Health Sci Res. 2013;3(1):13–8.
63. Odukoya OO, Odeyemi KA, Oyeyemi AS, Upadhyay RP. Determinants of
smoking initiation and susceptibility to future smoking among school-going
adolescents in Lagos State, Nigeria. APJCP. 2013;14(3):1747–53.
64. Okagua J, Opara P, Alex-Hart BA. Prevalence and determinants of cigarette
smoking among adolescents in secondary schools in Port Harcourt,
Southern Nigeria. Int J Adolesc Med Health. 2016;28(1):19–24.
65. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A
prevalence of cardiometabolic risk factors among a rural Yoruba south-
western Nigerian population: a population-based survey. Cardiovasc J Afr.
2010;21(1):26–31.
66. Onofa L Prevalence and pattern of drug abuse among students of three
tertiary institutions in Abeokuta: A Dissertation submitted to the West
African College of Physicians, Faculty of Psychiatry; 2006.
67. Onyeonoro UU, Chukwuonye II, Madukwe OO, Ukegbu AU, Akhimien MO,
Ogah OS. Awareness and perception of harmful effects of smoking in Abia
State, Nigeria. Niger J Cardiol. 2015;12(1):27.
68. Oshodi OY, Aina OF, Onajole AT. Substance use among secondary school
students in an urban setting in Nigeria: prevalence and associated factors.
Afr J Psychiatry. 2010;13(1):52–7.
Adeloye et al. BMC Public Health         (2019) 19:1719 Page 13 of 14
69. Owonaro P, Eniojukan J. Cigarette Smoking Practices, Perceptions and
Awareness of Government Policies among Pharmacy Students in Niger
Delta University in South-South Nigeria. UK J Pharm Biosci. 2015;3(5):20–9.
70. Owonaro P, Eniojukan J. The Prevalence and Contextual Correlates of
Smoking in Opokuma Clan of Bayelsa State, Nigeria. Int J Adv Pharm Biol
Chem. 2015;4(3):656–67.
71. Ozoh OB, Dania MG, Irusen EM. The Prevalence of Self-Reported Smoking
and Validation with Urinary Cotinine Among Commercial Drivers in Major
Parks in Lagos, Nigeria. J Public Health Afr. 2014;5(1):316.
72. Ozoh OB, Akanbi MO, Amadi CE, Vollmer W, Bruce N. The prevalence of and
factors associated with tobacco smoking behavior among long-distance
drivers in Lagos, Nigeria. Afr Health Sci. 2017;17(3):886–95.
73. Raji M, Abubakar I, Oche M, Kaoje A. Prevalence and determinants of
cigarette smoking among in school adolescents in Sokoto metropolis,
Northwest Nigeria. Int J Trop Med. 2013;8(3):81–6.
74. Raji M, Usman A, Umar M, Oladigbolu R, Kaoje A. Cigarette Smoking among
Out-of-School Adolescents in Sokoto Metropolis, North-West Nigeria. Health
Sci J. 2017;11(3).
75. Salawu F, Danburam A, Isa B, Agbo J. Cigarette smoking habits among
adolescents in northeast Nigeria. Internet J Epidemiol. 2010;8(1):1.
76. Shehu AU, Idris SH. Marijuana smoking among secondary school students in
Zaria, Nigeria: factors responsible and effects on academic performance.
Annals Afr Med. 2008;7(4):175–9.
77. Yisa IO, Lawoyin TO, Fatiregun AA, Emelumadu OF. Pattern of substance use
among senior students of command secondary schools in Ibadan, Nigeria.
Niger J Med. 2009;18(3):286–90.
78. Abasiubong F, Atting I, Bassey E, Ekott J. A comparative study of use of
psychoactive substances amongst secondary school students in two local
Government Areas of Akwa Ibom State, Nigeria. Niger J Clin Pract. 2008;
11(1):45–51.
79. Uwakwe R, Gureje O. Sociodemographic correlates of continuing tobacco
use - a descriptive report from the Nigerian Survey of Mental Health and
Wellbeing. Acta Psychiatr Scand. 2016;133(6):506–13.
80. Gureje O, Degenhardt L, Olley B, Uwakwe R, Udofia O, Wakil A, et al. A
descriptive epidemiology of substance use and substance use disorders in
Nigeria during the early 21st century. Drug Alcohol Depend. 2007;91(1):1–9.
81. Lasebikan VO, Ola BA. Prevalence and Correlates of Alcohol Use among a Sample
of Nigerian Semirural Community Dwellers in Nigeria. 2016;2016:2831594.
82. Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA.
Prevalence of dyslipidaemia in apparently healthy professionals in Asaba,
South South Nigeria. Niger J Clin Pract. 2008;11(4):330–5.
83. Forrest KY, Bunker CH, Kriska AM, Ukoli FA, Huston SL, Markovic N. Physical
activity and cardiovascular risk factors in a developing population. Med Sci
Sports Exerc. 2001;33(9):1598–604.
84. Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS.
Prevalence of cardiovascular disease risk factors among a Nigerian adult
population: relationship with income level and accessibility to CVD risks
screening. BMC Public Health. 2015;15:397.
85. Ezejimofor MC, Uthman OA, Maduka O, Ezeabasili AC, Onwuchekwa AC,
Ezejimofor BC, et al. The Burden of Hypertension in an Oil- and Gas-Polluted
Environment: A Comparative Cross-Sectional Study. American J Hypertens.
2016;29(8):925–33.
86. Ezekwesili CN, Ononamadu CJ, Onyeukwu OF, Mefoh NC. Epidemiological
survey of hypertension in Anambra state, Nigeria. Niger J Clin Pract. 2016;
19(5):659–67.
87. Ogah OS, Madukwe OO, Chukwuonye II, Onyeonoro UU, Ukegbu AU,
Akhimien MO, et al. Prevalence and determinants of hypertension in Abia
State Nigeria: results from the Abia State Non-Communicable Diseases and
Cardiovascular Risk Factors Survey. Ethn Dis. 2013;23(2):161–7.
88. Suleiman IA, AE O, Ganiyu KA. Prevalence and control of hypertension in a
Niger Delta semi urban community, Nigeria. Pharm Pract. 2013;11(1):24–9.
89. Ugwuja E, Ezenkwa U, Nwibo A, Ogbanshi M, Idoko O, Nnabu R. Prevalence
and determinants of hypertension in an agrarian rural community in
southeast Nigeria. Annals Med Health Sci Res. 2015;5(1):45–9.
90. Wahab KW, Okokhere PO, Ugheoke AJ, Oziegbe O, Asalu AF, Salami TA.
Awareness of warning signs among suburban Nigerians at high risk for
stroke is poor: a cross-sectional study. BMC Neurol. 2008;8:18.
91. Drope J, Schluger N, Cahn Z, Drope J, Hamill S, Islami F, et al. The Tobacco
Atlas. Atlanta. 2018.
92. Kale Y, Olarewaju I, Usoro A, Ilori E, Ogbonna N, Ramanandraibe N, et al.
Global adult tobacco survey: country report 2012. Abuja. 2012.
93. Adeoye O, Sowunmi A, Adewuyi G, Lofinmakin B, Osadolor U, Amoo EO,
et al Estimating the prevalence and health risks awareness of smoking in
Nigeria: A meta-analysis approach. Afr Popul Stud. 2018;32(1).
94. Bilano V, Gilmour S, Moffiet T, d'Espaignet ET, Stevens GA, Commar A, et al.
Global trends and projections for tobacco use, 1990–2025: an analysis of
smoking indicators from the WHO Comprehensive Information Systems for
Tobacco Control. Lancet (London, England). 2015;385(9972):966–76.
95. Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette
epidemic in developed countries. Tobacco Control. 1994;3(3):242–7.
96. Lo J, Patel P, Roberts B. A systematic review on tobacco use among civilian
populations affected by armed conflict. Tobacco Control. 2016;25(2):129–40.
97. Jawad M, Khader A, Millett C. Differences in tobacco smoking prevalence
and frequency between adolescent Palestine refugee and non-refugee
populations in Jordan, Lebanon, Syria, and the West Bank: cross-sectional
analysis of the Global Youth Tobacco Survey. Conflict Health. 2016;10:20.
98. Hussain NA, Akande M, Adebayo ET. Prevalence of cigarette smoking and
knowledge implications among Nigerian soldiers of its health. East Afr J
Public Health. 2010;7(1):81–3.
99. Vellios N, Ross H, Perucic A-M. Trends in cigarette demand and supply in
Africa. PloS One. 2018;13(8):e0202467.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Adeloye et al. BMC Public Health         (2019) 19:1719 Page 14 of 14
